Background And Objective: Patients with gynecologic malignancies experience high symptom burden associated with both their disease and sequelae of treatment, and are at risk for aggressive (and often futile) care at end-of-life. Early palliative care (PC) involvement is essential to improving quality of life in this population of patients through symptom management and advanced care planning discussions. The purpose of this review article is to discuss current PC screening tools used to trigger PC consultations for patients with gynecologic malignancies. PC screening tools are reviewed across both inpatient and outpatient clinical settings.
Methods: A literature search was conducted utilizing PubMed® and Excerpta Medica database (EMBASE®). Search terms included various combinations of palliative care, gynecologic oncology, gynecologic cancer, gynecologic malignancy, female genital tract cancer, trigger, consult, referral, and screen.
Key Content And Findings: A total of six PC referral methods for patients with gynecologic cancer were identified across 10 studies discovered in this literature search. PC referral tools reviewed included use of the surprise questions, presence of specific clinical triggers, Triggered Palliative Care Consultation (TPCC), Palliative Care Referral Protocol (PCRP), Patient Reported Outcomes Measurement Information System (PROMIS), and Symptom screening with Targeted Early Palliative care (STEP).
Conclusions: Despite increased interest in PC screening tools to prompt earlier referral for patients with gynecologic cancers, this topic has limited research with varying results of PC referral. While some screening tools reviewed appear promising, further research targeting patients with gynecologic cancer across treatments settings is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21037/apm-22-728 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Retraction Note: Comment on "Beyond the scalpel: the role of palliative care in neurosurgery".
Neurosurg Rev
January 2025
Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, 77, Chennai, Tamil Nadu, India.
NELBI score: a new clinical calculator of thirty-day mortality following systemic anticancer therapy in breast cancer patients near the end of life.
Breast Cancer
January 2025
Health Sciences University, Dr Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Aims And Objectives: Appropriately timed cessation of systemic anticancer treatments is an important part of a patient's quality of life (QoL). We aimed to determine the right time to discontinue systemic anticancer therapy (SACT) and switch to the best supportive care for patients with advanced breast cancer (BC) who are nearing the end of life.
Methods: We identified 200 BC patients who died within 30 days after palliative SACT.
Impact of Lesion Severity in Fetal Cardiac Counseling.
Pediatr Cardiol
January 2025
Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Approximately 1% of all live births in the USA are affected by congenital heart disease (CHD), the leading cause of congenital defect-related illness and infant death. Although technological innovations have improved CHD diagnosis in utero, variation among fetal cardiac counseling practices persists. Our study aims to evaluate physician counseling content based on cardiac defect complexity.
View Article and Find Full Text PDFHow I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.
Ann Hematol
January 2025
Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.
The prefibrotic phase of primary myelofibrosis (pre-PMF) represents a distinct subentity within the spectrum of myeloproliferative neoplasms (MPNs), recognized by the World Health Organization (WHO) and the International Consensus Classification (ICC). Pre-PMF is characterized by unique morphological, clinical, and molecular features, distinguishing it from essential thrombocythemia (ET) and overt myelofibrosis (overt-PMF). The diagnostic process for pre-PMF relies on bone marrow histology, identification of molecular mutations and exclusion of other myeloid neoplasms.
View Article and Find Full Text PDFVoices from the frontline: Perspectives from certified nurse practitioners, clinical nurse specialists and physician assistants at an Academic Medical Center.
J Am Assoc Nurse Pract
January 2025
Division of Endocrinology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Background: The COVID-19 pandemic has exacerbated already existing stressors within health care. In August 2020, a campus-wide COVID-19 well-being survey indicated high levels of burnout, stress, and mental health concerns among certified nurse practitioners (CNPs), clinical nurse specialists (CNSs), and physician assistants (PAs) within our Department of Medicine.
Purpose: In response to this survey, an interdisciplinary task force was formed by CNPs, CNSs, and PAs across departmental specialty divisions to conduct focus groups to gain a deeper understanding of workplace experience both prepandemic and during the COVID-19 pandemic.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!